Publication | Open Access
Application of Dynamic <sup>18</sup>F-FDG PET/CT for Distinguishing Intrapulmonary Metastases from Synchronous Multiple Primary Lung Cancer
11
Citations
38
References
2022
Year
It has been a big challenge to distinguish synchronous multiple primary lung cancer (sMPLC) from primary lung cancer with intrapulmonary metastases (IPM). We aimed to assess the clinical application of dynamic <sup>18</sup>F-FDG PET/CT in patients with multiple lung cancer nodules. We enrolled patients with multiple pulmonary nodules who had undergone dynamic <sup>18</sup>F-FDG PET/CT and divided them into sMPLC and IPM groups based on comprehensive features. The SUV<sub>max</sub>, fitted <i>K</i> <sub><i>i</i></sub> value based on dynamic scanning, and corresponding maximum diameter (<i>D</i> <sub>max</sub>) from the two largest tumors were determined in each patient. We determined the absolute between-tumor difference of SUV<sub>max</sub>/<i>D</i> <sub>max</sub> and <i>K</i> <sub><i>i</i></sub> /<i>D</i> <sub>max</sub> (ΔSUV<sub>max</sub>/<i>D</i> <sub>max</sub>; Δ<i>K</i> <sub><i>i</i></sub> /<i>D</i> <sub>max</sub>) and assessed the between-group differences. Further, the diagnostic accuracy was evaluated by ROC analysis and the correlation between ΔSUV<sub>max</sub>/<i>D</i> <sub>max</sub> and Δ<i>K</i> <sub><i>i</i></sub> /D<sub>max</sub> from all groups was determined. There was no significant difference for ΔSUV<sub>max</sub>/<i>D</i> <sub>max</sub> between the IPM and sMPLC groups, while the IPM group had a significantly higher Δ<i>K</i> <sub><i>i</i></sub> /D<sub>max</sub> than the sMPLC group. The AUC of Δ<i>K</i> <sub><i>i</i></sub> /<i>D</i> <sub>max</sub> for differentiating sMPLC from IPM was 0.80 (cut-off value of <i>K</i> <sub><i>i</i></sub> = 0.0059, sensitivity 79%, specificity 75%, <i>p</i> < 0.001). There was a good correlation (Pearson <i>r</i> = 0.91, 95% CI: 0.79-0.96, <i>p</i> < 0.0001) between ΔSUV<sub>max</sub>/<i>D</i> <sub>max</sub> and Δ<i>K</i> <sub><i>i</i></sub> /<i>D</i> <sub>max</sub> in the IPM group but not in the sMPLC group (Pearson <i>r</i> = 0.45, <i>p</i> > 0.05). Dynamic <sup>18</sup>F-FDG PET/CT could be a useful tool for distinguishing sMPLC from IPM. <i>K</i> <sub><i>i</i></sub> calculation based on Patlak graphic analysis could be more sensitive than SUV<sub>max</sub> in discriminating IPM from sMPLC in patients with multiple lung cancer nodules.
| Year | Citations | |
|---|---|---|
Page 1
Page 1